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Abstract: 
Since the discovery in 1964 of the Epstein-Barr virus (EBV) in African Burkitt lymphoma, this virus has 
been associated with a remarkably diverse range of cancer types. Because EBV persists in the B cells 
of the asymptomatic host, it can easily be envisaged how it contributes to the development of B-cell 
lymphomas. However, EBV is also found in other cancers, including T-cell/natural killer cell 
lymphomas and several epithelial malignancies. Explaining the aetiological role of EBV is challenging, 
partly because the virus probably contributes differently to each tumour and partly because the 
available disease models cannot adequately recapitulate the subtle variations in the virus-host 
balance that exist between the different EBV-associated cancers. A further challenge is to identify 
the co-factors involved; because most persistently infected individuals will never develop an EBV-
associated cancer, the virus cannot be working alone. This article will review what is known about 
the contribution of EBV to lymphoma development. Copyright (c) 2014 Pathological Society of Great 
Britain and Ireland. Published by John Wiley & Sons, Ltd. 
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